Iovance Biotherapeutics (IOVA) Tops Q1 EPS by 7c

Iovance Biotherapeutics (NASDAQ: IOVA) reported Q1 EPS of ($0.50), $0.07 better than the analyst estimate of ($0.57).

For earnings history and earnings-related data on Iovance Biotherapeutics (IOVA) click here.

You May Also Be Interested In

• Klarna shares tumble on weak full-year revenue guidance
• GLJ Research on Sell Rated Tesla (TSLA): 'We now see FSD as the main reason TSLA’s stock will bleed lower this year'
• Eltek Ltd (ELTK) Reports Q2 EPS of $0.41